Skip to main content
Clinical Trials/NCT01455623
NCT01455623CompletedNot Applicable

Development and Validation of a Disability Severity Index for Charcot Marie Tooth Disease

University of Iowa1 site in 1 country291 target enrollmentStarted: June 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
291
Locations
1
Primary Endpoint
Compare Patient and Healthcare Provider impressions of what constitutes mild, moderate and severe impairment in CMT

Study Overview

Brief Summary

It is necessary for outcome measures to accurately reflect the state of health of a person in order for clinical trials to show benefit. The most commonly used outcome measure for Charcot Marie Tooth Disease (CMT) is the CMT Neuropathy Score, which uses cutoffs of points designated as mild (0-10 points), moderate (11-20) or severe (21-36). These terms are arbitrary. This study is looking to base mild, moderate, and severe on what both people affected with CMT and those who provide for people with CMT consider appropriate.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
8 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • patients with CMT ages 8-100,
  • health care professionals who take care of patients with CMT.
  • Eligible patients will be patients that have joined the INC RDCRN Contact Registry. These will be patients or guardians with known or probable inherited neuropathies.
  • Eligible health care professionals who participate in the care of patients with inherited neuropathies (physicians, genetic counselors, physical and occupational therapists etc.) attending the 4th International CMT Consortium to be held in Potomac Maryland June 29-July 1, 2011.

Exclusion Criteria

  • Does not read or speak English.

Outcomes

Primary Outcomes

Compare Patient and Healthcare Provider impressions of what constitutes mild, moderate and severe impairment in CMT

Time Frame: 1 year

Secondary Outcomes

  • Develop a Disability Severity Index including items with high patient-physician concordance(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael Shy

Professor

University of Iowa

Study Sites (1)

Loading locations...

Similar Trials